Molbio Diagnostics Closes Trading Window for Q2 FY27 Results

Molbio Diagnostics Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended September 30, 2026. The specific date for the Board Meeting to consider these results will be communicated separately. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.